| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 65,287 | 114,850 | 106,630 | 69,756 | | Cost of Revenue | 43,674 | 68,755 | 66,662 | 44,650 | | | Gross Profit | 21,613 | 46,095 | 39,968 | 25,106 | | | Operating Expenses | | Research Development | 2,935 | 2,723 | 2,640 | 2,802 | | Selling General and Administrative | 28,864 | 32,786 | 31,536 | 27,527 | | Non Recurring | 697 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (10,883) | 10,586 | 5,792 | (5,223) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (362) | 439 | 497 | (1,016) | | Earnings Before Interest And Taxes | (11,245) | 11,025 | 6,289 | (6,239) | | Interest Expense | 2,583 | 2,647 | 3,121 | 1,598 | | Income Before Tax | (13,828) | 8,378 | 3,168 | (7,837) | | Income Tax Expense | 398 | (612) | 703 | (896) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,226) | 8,990 | 2,465 | (6,941) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 41 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,226) | 8,990 | 2,465 | (6,900) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,226) | $8,990 | $2,465 | ($6,900) |
|
0.31% Nasdaq 0.00%
Income Statement
